Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex Pharmaceuticals. | Mosaic ...

Despite a lot of advancements in our understanding of dementia over the past few decades, doctors still don’t have a reliable ...

A new fiber-optic device enables rapid, microscope-free detection of biomarkers using a gliding motility assay. The platform ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, that severely impacts motor and non-motor functions. Early detection and effective ...

The iCares bandage uses innovative microfluidic components, sensors, and machine learning to sample and analyze wounds and provide data to help patients and caregivers make treatment decisions.

By understanding a patient’s unique genetic profile, biomarker readings and lifestyle information, doctors could tailor the ...

A new study shows that brain connectivity patterns, especially in the dorsal anterior cingulate cortex, can help predict how patients with major depressive disorder (MDD) will respond to ...

The United States has seen progress in reducing certain cancer risks, as overall smoking rates remain on a decline.

Acting Governor Tahesha Way today signed legislation requiring state-regulated health insurers to cover biomarker testing.

New startup Superpower is jumping into the preventive health and longevity market offering personalized lab testing to give ...